Generation an induced pluripotent stem cell line SXMUi001-A derived from a hemophilia B patient carries variant F9 c.223C>T(p.R75X)

被引：3
|
作者：
Ma, Yanchun [1 ]
Sun, Wenwen [1 ]
Liu, Xiue [1 ]
Ren, Juan [1 ]
Zhang, Xialin [2 ]
Zhang, Ruijuan [2 ]
Zhao, Lidong [1 ]
Yang, Linhua [1 ]
Wang, Gang [1 ]
机构：
[1] Shanxi Med Univ, Dept Hematol, Hosp 2, Taiyuan 030001, Shanxi, Peoples R China
[2] Shanxi Med Univ, Shanxi Bethune Hosp, Tongji Shanxi Hosp, Shanxi Acad Med Sci,Hosp 3,Dept Hematol, Taiyuan 030032, Shanxi, Peoples R China
来源：
STEM CELL RESEARCH | 2022年 / 60卷
关键词：
D O I：
10.1016/j.scr.2022.102684
中图分类号：
Q813 [细胞工程];
学科分类号：
摘要：
Hemophilia B (HB) is an X chromosome-linked recessive disorder caused by a quantitative or qualitative defect of coagulation zymogen factor IX. In this study, urine cells were collected from a patient with HB who carries variant F9 c.223C > T (p.R75X), and reprogrammed into induced pluripotent stem cells (iPSCs) using the reprogramming factors, OCT4, SOX2, m-MYC, and KLF4. The HB-iPSC line (SXMUi001-A) has characteristics similar to human embryonic stem cell, namely, pluripotency and the potential to differentiate into three germ layers. This cell line can be used as a disease model for exploring the molecular mechanism and readthrough treatment of HB.
引用
收藏
页数：4
相关论文
共 50 条
  • [41] Generation of an induced pluripotent stem cell line (CSC-46) from a patient with Parkinson's disease carrying a novel p.R301C mutation in the GBA gene
    Gustavsson, Nadja
    Marote, Ana
    Pomeshchik, Yuriy
    Russ, Kaspar
    Azevedo, Carla
    Chumarina, Margarita
    Goldwurm, Stefano
    Collin, Anna
    Pinto, Luisa
    Salgado, Antonio J.
    Klementieva, Oxana
    Roybon, Laurent
    Savchenko, Ekaterina
    STEM CELL RESEARCH, 2019, 34
  • [42] Generation of the Rubinstein-Taybi syndrome type 2 patient-derived induced pluripotent stem cell line (IAIi001-A) carrying the EP300 exon 23 stop mutation c.3829A > T, p.(Lys1277*)
    Alari, Valentina
    Russo, Silvia
    Rovina, Davide
    Gowran, Aoife
    Garzo, Maria
    Crippa, Milena
    Mazzanti, Laura
    Scalera, Claudia
    Prosperi, Ennio
    Giardino, Daniela
    Gervasini, Cristina
    Finelli, Palma
    Pompilio, Giulio
    Larizza, Lidia
    STEM CELL RESEARCH, 2018, 30 : 175 - 179
  • [43] Generation of a gene-corrected human induced pluripotent stem cell line derived from a patient with laterality defects and congenital heart anomalies with a c.455G > A alteration in DAND5
    Inacio, Jose M.
    Almeida, Micael
    Cristo, Fernando
    Belo, Jose A.
    STEM CELL RESEARCH, 2020, 42
  • [44] Generation of an induced pluripotent stem cell (iPSC) line (IGIBi026-A) derived from Wilson disease patient harboring compound heterozygous mutations [c.2165dupT (p.R723Efs31) and c.C813A (p.C271*)] in the ATP7B gene
    Saikia, Bhaskar Jyoti
    Bhardwaj, Juhi
    Saini, Arti
    Rajan, Roopa
    Binukumar, B. K.
    STEM CELL RESEARCH, 2024, 81
  • [45] Human induced pluripotent stem cell line (ONHi001-A) generated from a patient with infantile neuroaxonal dystrophy having PLA2G6 c.517C > T (p.Q173X) and c.1634A > G (p.K545R) compound heterozygous mutations
    Fukusumi, Hayato
    Togo, Kazuyuki
    Beck, Goichi
    Shofuda, Tomoko
    Kanematsu, Daisuke
    Yamamoto, Atsuyo
    Sumida, Miho
    Baba, Kousuke
    Mochizuki, Hideki
    Kanemura, Yonehiro
    STEM CELL RESEARCH, 2023, 69
  • [46] Establishment of an induced pluripotent stem cell line from a Antley-Bixler Syndrome (ABS) patient with the homozygote mutation p.R457H (c.1370G>A) in POR gene
    Guo, Xiaoling
    Wang, Dexuan
    Shan, Xiaoou
    Yang, Liang
    Ding, Yinjuan
    Chen, Huihui
    Rong, Xing
    Chu, Maoping
    Lin, Jian
    Chen, Congde
    STEM CELL RESEARCH, 2021, 52
  • [47] Establishment of an induced pluripotent stem cell line (NCKDi003-A) from a patient with X-linked Dent disease (X-Dent) carrying the hemizygote mutation p. T277P (c. 829A > C) in the CLCN5 gene
    Hu, Lidan
    Wang, Gang
    Wu, Hangdi
    Fu, Haidong
    Wang, Yan
    Yu, Fan
    Liu, Zhihong
    Mao, Jianhua
    STEM CELL RESEARCH, 2021, 56
  • [48] Generation of an induced pluripotent stem cell line FDHPIi001-A derived from a female patient with WDR45-related neurodegeneration disease carrying non-canonical splice site c.344+5G > T
    Xiang, Jingjing
    Huang, Nana
    Qianqian, Ouyang
    Yi, Yuan
    Ding, Yang
    An, Yu
    STEM CELL RESEARCH, 2023, 66
  • [49] Generation of an induced pluripotent stem cell line from a 3-month-old nemaline myopathy patient with a heterozygous dominant c.515C > A (p Ala172Glu) variant in the ACTA1 gene .
    Clayton, Joshua S.
    Suleski, Isabella
    Vo, Christina
    Smith, Robert
    Scriba, Carolin K.
    Saker, Safaa
    Larmonier, Thierry
    Malfatti, Edoardo
    Romero, Norma B.
    Houweling, Peter J.
    Nowak, Kristen J.
    Ravenscroft, Gianina
    Laing, Nigel G.
    Taylor, Rhonda L.
    STEM CELL RESEARCH, 2022, 63
  • [50] Generation of an urine-derived induced pluripotent stem cell line WMUi017-A from a X-linked Renpenning syndrome (X-RSY) patient with the hemizygous PQBP1 gene mutation p.P609A (c.1825C>G)
    Guo, Xiaoling
    Zhang, Xufei
    Wang, Linlin
    He, Lingyun
    Ding, Yinjuan
    Chen, Huihui
    Wang, Dexuan
    Rong, Xing
    Shen, Xian
    Lin, Jian
    Chu, Maoping
    STEM CELL RESEARCH, 2021, 51
12345